Mark A. LaPack
Mark A. LaPack is research advisor, Small Molecule Design & Development, Eli Lilly and Company.
Articles
A Biopharmaceutical Industry Perspective on Single-Use Sensors for Biological Process Applications
Mark A. LaPack;Tony Y. Wang;Michael C. Brandenstein;Stacey M. Kaneshiro;Victor M. Saucedo;Seongkyu Yoon;Robert E. Kottmeier;Yuk Chun Chiu;Bradley H. Diehl;Yongchun Zhang
April 1st 2015This article presents first-hand perspectives from industry users to suppliers of single-use sensors.
Latest Updated Articles
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: October 28th 2024 | Updated: November 22nd 2024
Discovery to Commercialization: The Right Partnerships are Key to Streamlined Drug Development
Published: November 15th 2024 | Updated: November 22nd 2024
Solving Challenges with AAV Aggregate Analysis Using a Novel Size Exclusion Particle to Determine CQAs
Published: October 28th 2024 | Updated: November 22nd 2024
Cell-based phenotypic screening with Incucyte® Live-Cell Analysis Systems
Published: October 22nd 2024 | Updated: November 22nd 2024
Optimizing cGMP Facility Design Space with a Hybrid Approach
